SCHEMBL25890305

SCHEMBL25890305

CC1CN(C(C)C)CC1C(=O)N(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 1/20 0.32
DRD4 P21917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23323491 0.86 DRD4 (0.31) DRD4
SCHEMBL25953036 0.83 BCHE (0.33) DRD4
SCHEMBL23325006 0.81 ACKR3 (0.32) ACKR3
SCHEMBL25932127 0.80 ACKR3 (0.34) ACKR3
SCHEMBL15867757 0.76 BCHE (0.35) ACKR3
SCHEMBL27324166 0.75 ALDH1A1 (0.33)
SCHEMBL23324536 0.73 L3MBTL1 (0.32)
SCHEMBL2737211 0.73 HRH3 (0.43)
SCHEMBL20621211 0.73 ACKR3 (0.39) ACKR3
SCHEMBL19880561 0.73 ACKR3 (0.39) ACKR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234929-A1 RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234929-A1 RAS INHIBITORS KRAS, NRAS, HRAS ACKR3 3902/4885DRD4 4623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.